Parkinson’s and dementia with Lewy bodies blood test, CAR T-cell therapy for glioblastoma, wireless EEG

04/09/2025

Neurology Today in 5

0:00

4:27

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a promising blood test to distinguish Parkinson’s disease from dementia with Lewy bodies, how CAR T-cell therapies are showing potential for patients with glioblastoma, and a new wireless electroencephalogram device that can even monitor young children with epilepsy.

Mais episódios de "Neurology Today in 5"

Food deserts and stroke risk, physical activity in Parkinson’s disease, rimegepant for migraine
há um dia
4:51
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the relationship between income, “food deserts,” and stroke risk; why staying active may reduce cognitive decline in patients with Parkinson's disease; and how initiating rimegepant for migraine could help reduce opioid and butalbital use.
Parkinson’s and dementia with Lewy bodies blood test, CAR T-cell therapy for glioblastoma, wireless EEG
04/09/2025
4:27
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a promising blood test to distinguish Parkinson’s disease from dementia with Lewy bodies, how CAR T-cell therapies are showing potential for patients with glioblastoma, and a new wireless electroencephalogram device that can even monitor young children with epilepsy.
Não percas um episódio de “Neurology Today in 5” e subscrevê-lo na aplicação GetPodcast.
Small fiber neuropathy, Dr. Merit Cudkowicz, work-life balance for families of neurologists
21/08/2025
3:52
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about whether small fiber neuropathy is an autoimmune disorder; Merit Cudkowicz, MD, MSc, FAAN, recipient of this year’s AAN Lifetime Achievement Award for Clinically Relevant Research; and how neurologist couples pursue work-life balance.
Divisive treatment for cluster headache, head positioning before thrombectomy, new series, “Neurology in America”
07/08/2025
4:10
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about eptinezumab, a treatment for episodic cluster headache; how positioning the head flat before a thrombectomy benefited patients with large vessel occlusion stroke; and what rural neurology looks like in 2025, the first story in our new series, Neurology in America.
New treatment for giant-cell arteritis, links between oral and brain health, an emerging meningitis B vaccine
17/07/2025
4:34
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about upadacitinib, a new treatment for giant-cell arteritis; growing evidence linking oral health to a higher risk of neurologic conditions; and why a trial of a new meningitis B vaccine drew a mixed response.
Telomere length and and risk for neurologic disorders, impact of research cuts on promotion/tenure, herpes zoster vaccine and dementia
03/07/2025
4:51
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles on the association of shortened telomeres on risk for stroke, late-life depression and dementia; affect of research funding cuts on tenure/promotion opportunities; and herpes zoster vaccine and reduced dementia risk.
Post-TIA fatigue, neurologic complications of measles, CDC surveillance of epilepsy program dismantled.
19/06/2025
4:14
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles studies showing persistent fatigue after TIA, the neurologic complications of measles, and the impact of the dismantling of a CDC surveillance program of epilepsy.
Post-TIA fatigue, neurologic complications of measles, CDC surveillance of epilepsy program dismantled.
05/06/2025
4:27
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles studies showing persistent fatigue after TIA, the neurologic complications of measles, and the impact of the dismantling of a CDC surveillance program of epilepsy.
Advances in cell therapies for Parkinson’s, GLP-1 agonists and dementia risk, FDA accelerated approvals for neurology drugs
15/05/2025
4:14
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about early studies finding dopamine cellular therapies were safe and tolerable for patients with Parkinson’s, use of GLP-1 agonists were associated with reduced dementia risks, and the FDA use of accelerated approvals for several neurology drugs are under scrutiny.
Microplastics in brain, salary gap in neurology, the neurology of space
01/05/2025
4:16
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles finding microplastics in the brain postmortem linked to dementia, the salary gap between men and women neurologies, and neurologists studying the impact of microgravity on the brain.

Mais episódios

Descobre o mundo dos podcasts com a app gratuita GetPodcast.

Subscreve os teus podcasts preferidos, ouve episódios offline e obtém recomendações fantásticas.

Política de privacidade
Ficha técnica
Portugal

Parkinson’s and dementia with Lewy bodies blood test, CAR T-cell therapy for glioblastoma, wireless EEG

Neurology Today in 5

Mais episódios de "Neurology Today in 5"

Food deserts and stroke risk, physical activity in Parkinson’s disease, rimegepant for migraine

Parkinson’s and dementia with Lewy bodies blood test, CAR T-cell therapy for glioblastoma, wireless EEG

Small fiber neuropathy, Dr. Merit Cudkowicz, work-life balance for families of neurologists

Divisive treatment for cluster headache, head positioning before thrombectomy, new series, “Neurology in America”

New treatment for giant-cell arteritis, links between oral and brain health, an emerging meningitis B vaccine

Telomere length and and risk for neurologic disorders, impact of research cuts on promotion/tenure, herpes zoster vaccine and dementia

Post-TIA fatigue, neurologic complications of measles, CDC surveillance of epilepsy program dismantled.

Post-TIA fatigue, neurologic complications of measles, CDC surveillance of epilepsy program dismantled.

Advances in cell therapies for Parkinson’s, GLP-1 agonists and dementia risk, FDA accelerated approvals for neurology drugs

Microplastics in brain, salary gap in neurology, the neurology of space